KEENAN GREG (SVP, Chief Medical Officer) reported 1 transaction at AURINIA PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2026ACC: 0001600620-26-000024
Officer· SVP, Chief Medical Officer
Since Feb 2026
-8.07K
Net shares
Net seller
$115.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.07K
Price / share
$14.32
Trade value
$115.55K
% of position
5.0%
3/6/2026
162.52K→154.45K
Total
Net shares
−8.07K
Net value
-$115.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −8.07K | $14.32 | $115.55K | 5.0% | 162.52K | 154.45K |
| Total | −8.07K | -$115.55K | ||||||
Derivative Transactions0
No derivative transactions reported